Microdosing
Microdosing delivers short, fact-driven reports that distill today’s trending healthcare topics, and add fresh perspectives that are grounded in expert insights and credible sources. For written reports and bibliographies, please visit www.md-pod.com.
10
Where Journeys Collide; Designing Beyond a Single Healthcare Experience Map
<p>Every healthcare organization operates within a web ofoverlapping experience maps, including clinical, administrative, payer, patient, and policy maps. These maps shape every decision, workflow, and outcome. In healthcare, a customer experience (CX) map traces the steps, systems, and emotions that patients, clinicians, and staff move through as care is delivered and supported. Each map makes sense on its own, but the real complexity begins where they overlap. Most improvement efforts focus on a single map, yet few consider how these maps interact or depend on one another.</p><p></p>
The Monster in the Middle; Why Prior Authorization Wrecks the Patient Experience, and Why Everyone’s Trying to Tame It
<p>Every industry has a process that looks small on paper butshapes everything around it. In healthcare, that process is priorauthorization. It is the quiet monster that hides between doctors, payers, and patients, invisible to most until it strikes. When it does, it does not just delay care; it unravels trust, burns out staff, and corrodes the very idea of a coordinated patient journey.</p><p></p>
The Decentralizing of the Hospital Cafeteria; Why food service is the next frontier of healthcare innovation
<p>Hospitals were once the epicenter of healthcare food service. One kitchen fed thousands, one cafeteria served everyone from physicians to visitors, and one model defined the experience. That era is ending.</p><p>As care moves beyond the hospital walls into outpatient clinics, ambulatory centers, imaging hubs, and patients’ homes, food service needs to move with it. What once was a static operation is becoming a dynamic, distributed network designed to keep up with an always-on health system.</p>
The Quiet Rebellion; How Small Medical Practices Are Beating the Odds and Finding Margin in the Chaos
<p>For years, the story of American healthcare has read like an obituary for small, independent medical practices. Faced with shrinking reimbursements, staffing shortages, and rising administrative burden, many physicians traded autonomy for stability, selling to health systems or private equity. Yet beneath the consolidation headlines, a quiet rebellion is taking shape. Across the country, small specialty and multi-site practices are not only surviving but posting strong margins. They’re lean, tech-forward, and operationally disciplined, proving that small can be powerful when run like a high-performing business.</p>
Medication Management and the Myth of Patient Empowerment
<p></p><p>All around you, Healthcare leadership continues to lean on familiar solutions: more education, more empowerment, more reminders to improve adherence. It sounds polite,nonthreatening, and promising. But it’s also a comfortable excuse that obscures a deeper, systemic failure. Because the truth is: medication adherence—our most basic measure of patient engagement—remains stubbornly low. Despite decades of well-meaning interventions, the problem persists. This isn’t a patient failure. It’s a system failure.</p><p> </p><p></p>
Modern Primary Care Diagnostic Sequences
<p>Modern Primary Care Diagnostic Sequences; Why the Future of Care Hinges on Faster, Smarter Diagnostics. Traditionally, and still in many practices today, some of the most important parts of a primary care visit happen after the patient leaves the exam room. Diagnosis is often delayed, follow-up decisions are disconnected from the visit itself, and early opportunities for intervention can be missed. The diagnostic sequence may be the least celebrated yet the most essential part of a primary care visit. Whether it’s a healthy 25 year old seeking reassurance or a 45 year old at risk for diabetes, the pattern is th...
The Next Safety Gap; How Compounded GLP-1s Expose the Limits of Oversight
<p>As demand for GLP-1 drugs like Ozempic and Wegovy soars, a parallel market for compounded versions has emerged — one that’s largely unregulated and increasingly risky. This episode examines how gaps in oversight, aggressive marketing, and blurred lines between compounding and manufacturing expose patients to safety concerns and strain the health system. We explore why compounded GLP-1s are more than a niche issue, highlighting how they fit a recurring pattern where regulation lags behind fast-moving markets.</p>
The Domino Effect; How Shifts in Medicaid and Medicare Advantage Reshape Everyone’s Insurance
<p>Medicaid and Medicare Advantage may seem like programs for specific groups, but the choices made in these public plans ripple across the entire insurance system. This episode explores how coverage churn, capped benefits, and financing reforms in public programs ultimately shape commercial premiums, provider networks, and patient access for everyone. We unpack why what starts in Medicaid and Medicare Advantage rarely stays there, and how those shifts end up reshaping all of our coverage.</p>
The 3 Ps Reshaping Care: Primary Care, Pricing, and Place
<p>Primary care consolidation is changing how patients experience — and pay for — everyday healthcare. This episode examines how ownership, pricing, and place intersect to drive up costs, with research from The Journal of the American Medical Association showing that hospital and private equity–affiliated practices charge more without delivering clear quality gains. We unpack what this hidden shift means for patients, insurers, and the future of affordable primary care.</p>
America’s Only Unregulated Product; Firearms and the Public Health Gap
<p>Firearms have become the leading cause of death among U.S. children and teens, yet unlike cars, toys, or even e-cigarettes, they remain exempt from basic consumer safety regulation. This episode explores the public health and economic costs of treating guns as constitutionally protected products rather than consumer goods, drawing on recent research and commentaries from The Journal of the American Medical Association (JAMA) and JAMA Health Forum. We highlight what a true public health approach could look like (from child locks to smart-gun technology) and why closing this regulatory gap could save lives and reduce systemwide costs.</p>
